ISSN: 2332-0877

Journal of Infectious Diseases & Therapy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review   
  • J Infect Dis Ther 2018, Vol 6(2): 360
  • DOI: 10.4172/2332-0877.1000360

HCV Infection on Lymphoid Neoplasm

Yutaka Tsutsumi1*, Yoshiya Yamamoto2, Shinichi Ito1, Takahiro Sekine1, Satomi Matsuoka1, Hirohito Naruse2 and Takanori Teshima3
1Department of Hematology, Hakodate Municipal Hospital, , Hakodate, 1-10-1, Minato-cho, Hakodate 041-8680, Japan
2Department of Gastroenterology, Hakodate Municipal Hospital, , Hakodate, 1-10-1, Minato-cho, Hakodate 041-8680, Japan
3Department of Hematology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
*Corresponding Author : Yutaka Tsutsumi, Department of Hematology, Hakodate Municipal Hospital 1-10-1, Minato-cho, Hakodate 041-8680, Japan, Tel: +81-138-43-2000, Fax: +81-138-43-4426, Email: yutsutsu@shore.ocn.ne.jp

Received Date: Apr 15, 2018 / Accepted Date: Apr 19, 2018 / Published Date: Apr 23, 2018

Abstract

Since there is a suggested a link between HCV and liver cancer, attempts are currently being made to discover new drugs that can advance the treatment of hepatitis C and prevent it from progressing to liver cancer. On the other hand, in the treatment of lymphoma, it has been pointed out that HCV is associated with HCV reactivation and lymphoproliferative diseases such as lymphoma. In this review, we will summarize the relationship between lymphoproliferative diseases and hepatitis due to reactivation of HCV during treatment with rituximab.

Keywords: Rituximab; Hepatitis C virus (HCV); Lamivudine; Non- Hodgkin’s lymphoma (NHL); Direct-acting anti-viral agents (DAA)

Citation: Tsutsumi Y, Yamamoto Y, Ito S, Sekine T, Matsuoka S, et al. (2018) HCV Infection on Lymphoid Neoplasm. J Infect Dis Ther 6: 360. Doi: 10.4172/2332-0877.1000360

Copyright: © 2018 Tsutsumi Y, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium.

Top